医疗信息服务提供商Elsevier收购Wellsheet，以弥合临床诊疗点上患者数据与临床证据之间的差距-动脉网

Elsevier acquires Wellsheet to close the gap between patient data and clinical evidence at the point of care

CISION 等信源发布 2026-06-03 20:30



可切换为仅中文







Elsevier's ClinicalKey AI and Wellsheet will deliver verifiable clinical evidence and patient context directly into the EHR, giving clinicians governed AI answers within their existing workflows

爱思唯尔的 ClinicalKey AI 和 Wellsheet 将可验证的临床证据和患者背景信息直接整合到电子健康记录（EHR）中，使临床医生能够在现有工作流程中获得受控的人工智能答案。

NEW YORK

纽约

，

June 3, 2026

2026年6月3日

/PRNewswire/ -- Elsevier today announced it has acquired

/美通社/ -- 爱思唯尔今日宣布已收购

Wellsheet

井单

, a US-based health technology company that specializes in aggregating and synthesizing patient data from

，一家总部位于美国的健康科技公司，专门从事患者数据的聚合与综合处理

electronic health records (EHR)

电子健康记录（EHR）

to surface relevant clinical intelligence at the point of care. Together, Wellsheet's validated EHR data model and ClinicalKey AI's peer-reviewed evidence base will give clinicians verified, patient-specific guidance to help clinicians make vital decisions seamlessly at the point of care.

在诊疗现场提供相关的临床智能。Wellsheet 经过验证的电子健康记录（EHR）数据模型与 ClinicalKey AI 经同行评审的证据基础相结合，将为临床医生提供经过验证的、针对患者个体的指导，帮助他们在诊疗现场无缝地做出关键决策。

According to a 2026 McKinsey & Company healthcare study, more than half of US healthcare leaders surveyed said the biggest barrier to scaling gen AI is difficulty integrating into existing workflows.

根据麦肯锡公司2026年的一项医疗保健研究，超过半数的受访美国医疗保健领导者表示，规模化应用生成式人工智能的最大障碍是难以将其整合到现有工作流程中。

[i]

Clinicians today must navigate complex patient records, rapidly evolving guidelines, and growing documentation demands — often across disconnected tools. By combining Elsevier's trusted clinical evidence, precision AI and domain expertise with Wellsheet's validated EHR data model, the company's integrated offering will .

当今的临床医生必须在复杂的患者病历、快速演变的指南以及日益增长的文档需求之间游刃有余，而这些工作往往需要在彼此孤立的工具间切换。通过将爱思唯尔（Elsevier）可信的临床证据、精准人工智能与领域专业知识，与 Wellsheet 经过验证的电子健康记录（EHR）数据模型相结合，该公司的集成化产品将

bring patient

带患者来

–

specific guidance to the point of care, inside the workflow where clinical decisions are made

在临床决策所在的工作流程中，提供直达诊疗点的具体指导

. This includes:

。这包括：

Aggregating and synthesizing large volumes of data into a relevant patient view, giving clinicians immediate context without additional searching;

将海量数据聚合并综合成相关的患者视图，使临床医生无需额外搜索即可立即获得上下文信息；

Surfacing trusted clinical content and guidelines from

呈现来自的可信临床内容和指南

ClinicalKey AI

, including thousands of peer-reviewed journals with every response traceable to its source;

，包括数千种同行评审期刊，且每次回复均可追溯至其来源；

Guiding discharge planning, follow-up actions, and reducing gaps in care.

指导出院计划、随访行动，并减少护理过程中的差距。

Omry Bigger, President, Clinical Solutions, Elsevier, said: 'Clinicians today face a genuine tension: the patient data they need is in complex EHR systems, and the trusted evidence they need is somewhere else entirely. That gap costs time and introduces risk. By combining Wellsheet's proven EHR data aggregation platform with ClinicalKey AI's trusted evidence base, we're closing it to deliver verified, patient-specific guidance directly inside the clinical workflow.

爱思唯尔临床解决方案总裁 Omry Bigger 表示：“如今的临床医生面临着真正的困境：他们所需的患者数据存在于复杂的电子健康记录（EHR）系统中，而他们信赖的循证证据则完全位于其他地方。这种差距不仅耗费时间，还带来风险。通过将 Wellsheet 经过验证的 EHR 数据聚合平台与 ClinicalKey AI 的可靠循证数据库相结合，我们正在弥合这一差距，从而在临床工作流中直接提供经过验证的、针对特定患者的指导。”

For health systems, this means governed AI at the point of care, built on verified content clinicians can trust and patient context they already have.'.

对于医疗系统而言，这意味着在护理点部署受治理的人工智能，其基础是临床医生可信赖的经过验证的内容，以及他们已掌握的患者背景信息。

Wellsheet brings proven expertise in rapidly aggregating and structuring complex EHR data, enabling fast implementation across major EHR platforms. The combined capabilities strengthen Elsevier's broader Clinical Solutions portfolio, supporting future advances in decision support, care pathways, patient engagement, and analytics..

Wellsheet 在快速聚合和构建复杂电子健康记录（EHR）数据方面拥有经过验证的专业知识，能够在主要 EHR 平台上实现快速部署。这些整合后的能力增强了爱思唯尔更广泛的临床解决方案产品组合，支持决策支持、护理路径、患者参与和分析等领域的未来进展。

Craig Limoli, CEO and Co-Founder, Wellsheet said: 'Elsevier and Wellsheet are well positioned to address the complex needs of clinicians and hospital systems and scale at a faster pace. Wellsheet is already available across major EHR systems, and that footprint, combined with Elsevier's global reach, gives us a clear path to bring this capability to health systems everywhere.

Wellsheet 首席执行官兼联合创始人 Craig Limoli 表示：“Elsevier 和 Wellsheet 具备良好优势，能够满足临床医生和医院系统的复杂需求，并实现更快速的规模化发展。Wellsheet 已接入各大主流电子健康记录（EHR）系统，这一基础结合 Elsevier 的全球覆盖能力，为我们向世界各地的医疗系统提供此项服务指明了清晰路径。”

Together, we're giving clinicians verified clinical insights and providing health systems with the consistency, security, and quality oversight they need to utilize AI with confidence.'.

我们携手为临床医生提供经过验证的临床洞察，并为医疗系统提供其 confidently 应用人工智能所需的一致性、安全性和质量监管。

Elsevier will integrate Wellsheet into its

爱思唯尔将把 Wellsheet 整合到其

Clinical Solutions

临床解决方案

business, which addresses the needs of clinicians, providers and care teams in three key areas: building clinical competencies; supporting informed clinical decisions; and providing patient engagement solutions built on evidence-based information. Wellsheet is currently deployed across 139 hospital sites in the US, and integrated into major EHR systems..

该业务旨在满足临床医生、医疗服务提供者及护理团队在三个关键领域的需求：构建临床能力、支持基于信息的临床决策，以及提供以循证信息为基础的患者参与解决方案。Wellsheet 目前已在美国 139 家医院部署，并集成到各大电子健康记录（EHR）系统中。

The company's

公司的

ClinicalKey AI

is a leading clinical decision support solution that provides

是一款领先的临床决策支持解决方案，提供

comprehensive evidence-based medical information, including full-text content and clinical

全面的循证医学信息，包括全文内容和临床

practice guidelines from more than 1,000 medical journals and organizations

来自1000多种医学期刊和组织的实践指南

. Currently in use in more than 300 hospitals across the world, ClinicalKey AI's medical content includes

目前，ClinicalKey AI 的医学内容已在全球 300 多家医院中使用，包括

The

这

Lancet

柳叶刀

series, Chest, Journal of Allergy and Clinical Immunology, Journal of Thoracic Oncology

系列，《Chest》，《过敏与临床免疫学杂志》，《胸科肿瘤学杂志》

, and

，以及

American Journal of Obstetrics and Gynecology

《美国妇产科杂志》

and guidelines from renowned organizations such as the American College of Cardiology, the American Association of Clinical Endocrinology, the European Society for Medical Oncology, the American College of Emergency Physicians, the American Gastroenterological Association and more.

以及来自美国心脏病学会、美国临床内分泌医师协会、欧洲肿瘤内科学会、美国急诊医师学院、美国胃肠病学会等知名组织的指南。

About Elsevier

关于爱思唯尔

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work..

爱思唯尔是全球先进的信息与决策支持领域的领导者。一个多世纪以来，我们一直致力于推动科学与医疗健康的发展，以促进人类进步。我们为遍布170个国家的学术界和企业界研究社群、医生、护士、未来医疗健康专业人员以及教育工作者提供支持，助力他们开展至关重要的工作。

We help impact makers achieve better outcomes with research and clinical-grade solutions built on the world's leading scientific and medical knowledge base of evidence-based content, precision AI, and expert human assessment to ensure accountability at every step.

我们帮助影响力创造者通过研究和临床级解决方案实现更好的成果，这些解决方案建立在全球领先的基于证据的内容、精准人工智能和专家人工评估的科学和医学知识库之上，以确保每一步的责任落实。

We champion inclusion and sustainability, working with the communities that we serve.

我们倡导包容性与可持续发展，与我们所服务的社区携手合作。

The Elsevier Foundation

爱思唯尔基金会

supports research and health partnerships around the world.

支持全球范围内的研究与健康合作伙伴关系。

Elsevier is part of

爱思唯尔是

RELX

, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit

，一家为全球专业和商业客户提供基于信息的分析和决策工具的公司。欲了解更多信息，请访问